SCHEMBL17644162

SCHEMBL17644162

O=C(ON=C(CC1CCCC1)C(=O)c1ccc(Sc2ccccc2)cc1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.37
NPC1 O15118 4/20 0.37
RAB9A P51151 4/20 0.37
PKM P14618 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
MAPT P10636 2/20 0.37
ALDH1A1 P00352 2/20 0.37
HPGD P15428 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
LMNA P02545 1/20 0.36
MGLL Q99685 1/20 0.36
KDM4E B2RXH2 1/20 0.36
GAA P10253 1/20 0.36
CDK5 Q00535 3/20 0.36
CDK5R1 Q15078 3/20 0.36
MITF O75030 1/20 0.36
CHEK2 O96017 1/20 0.35
EPHX2 P34913 1/20 0.35
TNF P01375 1/20 0.35
KLF5 Q13887 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15960798 1.00 POLB (0.37) POLBNPC1RAB9APKMSMN1; SMN2
SCHEMBL17070002 1.00 POLB (0.37) POLBNPC1RAB9APKMSMN1; SMN2
SCHEMBL17069998 0.99 POLB (0.39) POLBNPC1RAB9APKMSMN1; SMN2
SCHEMBL31621087 0.99 POLB (0.39) POLBNPC1RAB9APKMSMN1; SMN2
SCHEMBL17540445 0.99 POLB (0.39) POLBNPC1RAB9APKMSMN1; SMN2
SCHEMBL17540446 0.95 NPC1 (0.39) POLBNPC1RAB9APKMSMN1; SMN2
SCHEMBL20015387 0.89 CYSLTR2 (0.34) POLBALDH1A1L3MBTL1LMNACHEK2
SCHEMBL25373230 0.89 L3MBTL1 (0.44) NPC1RAB9APKMSMN1; SMN2MAPT
SCHEMBL17070001 0.89 L3MBTL1 (0.44) NPC1RAB9APKMSMN1; SMN2MAPT
SCHEMBL19795438 0.89 L3MBTL1 (0.44) NPC1RAB9APKMSMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 747 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4565378-B1 METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA SICPA HOLDING SA (CH) 2026-05-06 EP claimed
US-20260015799-A1 METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA SICPA HOLDING SA (CH) 2026-01-15 US claimed
US-20250187036-A1 METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA SICPA HOLDING SA (CH) 2025-06-12 US claimed
EP-4565378-A1 METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA Sicpa Holding SA (CH) 2025-06-11 EP claimed
CN-118829493-A Method for producing an optical effect layer comprising magnetic or magnetizable pigment particles and exhibiting more than one marking 锡克拜控股有限公司 2024-10-22 CN claimed
EP-4429872-A1 VAT POLYMERIZATION PROCESS Polyfos 3D Ltd (IL) 2024-09-18 EP claimed
WO-2024028408-A1 METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA SICPA HOLDING SA (CH) 2024-02-08 WO claimed
WO-2023084517-A1 VAT POLYMERIZATION PROCESS POLYFOS 3D LTD (IL) 2023-05-19 WO claimed
CN-122072433-A Photosensitive resin composition for black resist, method for producing resin composition, light-shielding film, optical filter, touch panel, and display device 日铁化学材料株式会社 2026-05-22 CN disclosed
EP-4565378-B1 METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA SICPA HOLDING SA (CH) 2026-05-06 EP disclosed
US-12552888-B2 Curable resin composition and display device SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2026-02-17 US disclosed
US-12528983-B2 Curable resin composition and display device SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2026-01-20 US disclosed
US-12522742-B2 Photosensitive composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2026-01-13 US disclosed
US-12504564-B2 Layered body and display device SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2025-12-23 US disclosed
US-20170052448-A1 RESIST-PATTERN-FORMING METHOD AND CHEMICALLY AMPLIFIED RESIST MATERIAL OSAKA UNIVERSITY (JP) 2017-02-23 US disclosed
EP-3133445-A1 CHEMICALLY AMPLIFIED RESIST MATERIAL OSAKA UNIVERSITY (JP) 2017-02-22 EP disclosed
EP-3133444-A1 CHEMICALLY AMPLIFIED RESIST MATERIAL, PATTERN-FORMING METHOD, COMPOUND, AND PRODUCTION METHOD OF COMPOUND OSAKA UNIVERSITY (JP) 2017-02-22 EP disclosed
EP-3109703-A1 PHOTOSENSITIZATION CHEMICAL-AMPLIFICATION TYPE RESIST MATERIAL, METHOD FOR FORMING PATTERN USING SAME, SEMICONDUCTOR DEVICE, MASK FOR LITHOGRAPHY, AND TEMPLATE FOR NANOIMPRINTING Tokyo Electron Limited (JP) 2016-12-28 EP disclosed
US-20160357103-A1 PHOTOSENSITIZATION CHEMICAL-AMPLIFICATION TYPE RESIST MATERIAL, METHOD FOR FORMING PATTERN USING SAME, SEMICONDUCTOR DEVICE, MASK FOR LITHOGRAPHY, AND TEMPLATE FOR NANOIMPRINTING TOKYO ELECTRON LIMITED (JP) 2016-12-08 US disclosed
EP-3002632-A1 ACRYLIC PHOTOCURABLE COMPOSITION Changzhou Tronly Advanced Electronics Materials Co., Ltd. (CN) 2016-04-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12552888-B2 Curable resin composition and display device RAD51, LPO, FTO POLB 1138/4885NPC1 4339/4885RAB9A 1099/4885
US-12528983-B2 Curable resin composition and display device TIPRL, NLRP1, RCSD1 POLB 4026/4885NPC1 3860/4885RAB9A 1179/4885
US-20260015799-A1 METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA IK, TEX10, INCENP POLB 1111/4885NPC1 843/4885RAB9A 1702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.